BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23178978)

  • 1. The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma.
    Diouf M; Filleron T; Barbare JC; Fin L; Picard C; Bouché O; Dahan L; Paoletti X; Bonnetain F
    J Hepatol; 2013 Mar; 58(3):509-21. PubMed ID: 23178978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients with hepatocellular carcinoma received surgical resection.
    Lee LJ; Chen CH; Yao G; Chung CW; Sheu JC; Lee PH; Tsai YJ; Wang JD
    J Surg Oncol; 2007 Jan; 95(1):34-9. PubMed ID: 17192864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.
    Diouf M; Bonnetain F; Barbare JC; Bouché O; Dahan L; Paoletti X; Filleron T
    Oncologist; 2015 Jan; 20(1):62-71. PubMed ID: 25542450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials.
    Bonnetain F; Paoletti X; Collette S; Doffoel M; Bouché O; Raoul JL; Rougier P; Masskouri F; Barbare JC; Bedenne L
    Qual Life Res; 2008 Aug; 17(6):831-43. PubMed ID: 18618292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of liver function and quality of life of patients with liver cancer.
    Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
    BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting.
    Tournoux-Facon C; Paoletti X; Barbare JC; Bouché O; Rougier P; Dahan L; Lombard-Bohas C; Faroux R; Raoul JL; Bedenne L; Bonnetain F
    J Hepatol; 2011 Jan; 54(1):108-14. PubMed ID: 21047696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role functioning is associated with survival in patients with hepatocellular carcinoma.
    Meier A; Yopp A; Mok H; Kandunoori P; Tiro J; Singal AG
    Qual Life Res; 2015 Jul; 24(7):1669-75. PubMed ID: 25502092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
    Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
    Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein.
    Liu J; Wang Y; Zhang D; Liu B; Ou Q
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):186-94. PubMed ID: 22081008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life as a prognostic factor for survival in hepatocellular carcinoma.
    Sternby Eilard M; Hagström H; Mortensen KE; Wilsgaard T; Vagnildhaug OM; Dajani O; Stål P; Rizell M
    Liver Int; 2018 May; 38(5):885-894. PubMed ID: 28941130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30.
    Phillips R; Gandhi M; Cheung YB; Findlay MP; Win KM; Hai HH; Yang JM; Lobo RR; Soo KC; Chow PK
    J Clin Epidemiol; 2015 Aug; 68(8):895-902. PubMed ID: 25843232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.
    Tateishi R; Yoshida H; Shiina S; Imamura H; Hasegawa K; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Makuuchi M; Omata M
    Gut; 2005 Mar; 54(3):419-25. PubMed ID: 15710994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis of hepatocellular carcinoma according to new staging classifications].
    Caselitz M; Masche N; Flemming P; Stern C; Manns MP; Wagner S; Kubicka S
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1725-30. PubMed ID: 15295682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
    Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems.
    Cammà C; Di Marco V; Cabibbo G; Latteri F; Sandonato L; Parisi P; Enea M; Attanasio M; Galia M; Alessi N; Licata A; Latteri MA; Craxì A
    Aliment Pharmacol Ther; 2008 Jul; 28(1):62-75. PubMed ID: 18373636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.
    Yeo W; Mo FK; Koh J; Chan AT; Leung T; Hui P; Chan L; Tang A; Lee JJ; Mok TS; Lai PB; Johnson PJ; Zee B
    Ann Oncol; 2006 Jul; 17(7):1083-9. PubMed ID: 16600982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
    Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
    Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.
    Chow PK; Tai BC; Tan CK; Machin D; Win KM; Johnson PJ; Soo KC;
    Hepatology; 2002 Nov; 36(5):1221-6. PubMed ID: 12395333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.